Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the ...

The researchers found that RSV vaccination was 82.3% effective in protecting against hospital admission for participants with ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

More severe symptoms of RSV include rapid breathing, difficulty breathing such as babies flaring their nostrils, ribs sucking ...

The 2025–26 respiratory syncytial virus (RSV) season is shaping up to be a pivotal moment in the fight against this significant global health threat. In just the past 2 years, three products have been ...

RSV is a leading cause of infant hospitalizations in Canada, with older people and those who are immunocompromised also at greater risk ...

RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors, and people with medical ...

The long-acting monoclonal antibody nirsevimab (Beyfortus) protects children younger than 2 years from respiratory syncytial ...

Credit: Getty Images. RSV primarily affects children and older adults, and can lead to severe illness or death. Respiratory syncytial virus (RSV) affects infants, young children, and older adults, ...

Pune: A recent cluster of severe respiratory syncytial virus (RSV) cases progressing rapidly into viral pneumonia in the city ...

Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.